PEGylated Liposomal Vancomycin: A Glimmer of Hope for Improving Treatment Outcomes in MRSA Pneumonia

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|7|3|205-212

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.7, Iss.3, 2012-10, pp. : 205-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linezolid - The First Oxazolidinone in the Treatment of Nosocomial MRSA Pneumonia

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 123-130

Bentham Science Publishers

Access to resources Recommend Favorite

Optimizing Treatment Outcomes in Severe Community-Acquired Pneumonia

By Rodriguezdecastro F.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 1, 2003-01 ,pp. : 39-54

Adis International

Access to resources Recommend Favorite

Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes

By Alonso Rodrigo   Mata Pedro   Zambón Daniel   Mata Nelva   Fuentes-Jiménez Francisco  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 327-342

Informa Healthcare

Access to resources Recommend Favorite

Pneumonia Due to Methicilin-Resistant Staphylococcus aureus (MRSA): A Review

By  

Current Respiratory Medicine Reviews, Vol. 8, Iss. 3, 2012-06 ,pp. : 245-258

Bentham Science Publishers

Access to resources Recommend Favorite

Community-Associated Methicillin Resistant Staphylococcus aureus Pneumonia (CA-MRSA)

By  

Current Respiratory Medicine Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite